297 related articles for article (PubMed ID: 10097181)
1. A mutation in the transmembrane/luminal domain of the ryanodine receptor is associated with abnormal Ca2+ release channel function and severe central core disease.
Lynch PJ; Tong J; Lehane M; Mallet A; Giblin L; Heffron JJ; Vaughan P; Zafra G; MacLennan DH; McCarthy TV
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):4164-9. PubMed ID: 10097181
[TBL] [Abstract][Full Text] [Related]
2. An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor.
Monnier N; Romero NB; Lerale J; Nivoche Y; Qi D; MacLennan DH; Fardeau M; Lunardi J
Hum Mol Genet; 2000 Nov; 9(18):2599-608. PubMed ID: 11063719
[TBL] [Abstract][Full Text] [Related]
3. Caffeine and halothane sensitivity of intracellular Ca2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and/or central core disease.
Tong J; Oyamada H; Demaurex N; Grinstein S; McCarthy TV; MacLennan DH
J Biol Chem; 1997 Oct; 272(42):26332-9. PubMed ID: 9334205
[TBL] [Abstract][Full Text] [Related]
4. Measurement of resting cytosolic Ca2+ concentrations and Ca2+ store size in HEK-293 cells transfected with malignant hyperthermia or central core disease mutant Ca2+ release channels.
Tong J; McCarthy TV; MacLennan DH
J Biol Chem; 1999 Jan; 274(2):693-702. PubMed ID: 9873004
[TBL] [Abstract][Full Text] [Related]
5. Functional consequences of mutations of conserved, polar amino acids in transmembrane sequences of the Ca2+ release channel (ryanodine receptor) of rabbit skeletal muscle sarcoplasmic reticulum.
Du GG; MacLennan DH
J Biol Chem; 1998 Nov; 273(48):31867-72. PubMed ID: 9822655
[TBL] [Abstract][Full Text] [Related]
6. Ca2+ signaling in HEK-293 and skeletal muscle cells expressing recombinant ryanodine receptors harboring malignant hyperthermia and central core disease mutations.
Brini M; Manni S; Pierobon N; Du GG; Sharma P; MacLennan DH; Carafoli E
J Biol Chem; 2005 Apr; 280(15):15380-9. PubMed ID: 15689621
[TBL] [Abstract][Full Text] [Related]
7. A novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree.
Brown RL; Pollock AN; Couchman KG; Hodges M; Hutchinson DO; Waaka R; Lynch P; McCarthy TV; Stowell KM
Hum Mol Genet; 2000 Jun; 9(10):1515-24. PubMed ID: 10888602
[TBL] [Abstract][Full Text] [Related]
8. Functional effects of central core disease mutations in the cytoplasmic region of the skeletal muscle ryanodine receptor.
Avila G; Dirksen RT
J Gen Physiol; 2001 Sep; 118(3):277-90. PubMed ID: 11524458
[TBL] [Abstract][Full Text] [Related]
9. Mutations to Gly2370, Gly2373 or Gly2375 in malignant hyperthermia domain 2 decrease caffeine and cresol sensitivity of the rabbit skeletal-muscle Ca2+-release channel (ryanodine receptor isoform 1).
Du GG; Oyamada H; Khanna VK; MacLennan DH
Biochem J; 2001 Nov; 360(Pt 1):97-105. PubMed ID: 11695996
[TBL] [Abstract][Full Text] [Related]
10. Characterization of recombinant rabbit cardiac and skeletal muscle Ca2+ release channels (ryanodine receptors) with a novel [3H]ryanodine binding assay.
Du GG; Imredy JP; MacLennan DH
J Biol Chem; 1998 Dec; 273(50):33259-66. PubMed ID: 9837897
[TBL] [Abstract][Full Text] [Related]
11. The pore region of the skeletal muscle ryanodine receptor is a primary locus for excitation-contraction uncoupling in central core disease.
Avila G; O'Connell KM; Dirksen RT
J Gen Physiol; 2003 Apr; 121(4):277-86. PubMed ID: 12642598
[TBL] [Abstract][Full Text] [Related]
12. Detection of a novel ryanodine receptor subtype 1 mutation (R328W) in a malignant hyperthermia family by sequencing of a leukocyte transcript.
Loke JC; Kraev N; Sharma P; Du G; Patel L; Kraev A; MacLennan DH
Anesthesiology; 2003 Aug; 99(2):297-302. PubMed ID: 12883402
[TBL] [Abstract][Full Text] [Related]
13. Excitation--contraction uncoupling by a human central core disease mutation in the ryanodine receptor.
Avila G; O'Brien JJ; Dirksen RT
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4215-20. PubMed ID: 11274444
[TBL] [Abstract][Full Text] [Related]
14. A central core disease mutation in the Ca
Chirasani VR; Xu L; Addis HG; Pasek DA; Dokholyan NV; Meissner G; Yamaguchi N
Am J Physiol Cell Physiol; 2019 Aug; 317(2):C358-C365. PubMed ID: 31166712
[TBL] [Abstract][Full Text] [Related]
15. Ca2+ activation of RyR1 is not necessary for the initiation of skeletal-type excitation-contraction coupling.
O'Brien JJ; Feng W; Allen PD; Chen SR; Pessah IN; Beam KG
Biophys J; 2002 May; 82(5):2428-35. PubMed ID: 11964231
[TBL] [Abstract][Full Text] [Related]
16. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
McCarthy TV; Quane KA; Lynch PJ
Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202
[TBL] [Abstract][Full Text] [Related]
17. Reduced threshold for store overload-induced Ca
Chen W; Koop A; Liu Y; Guo W; Wei J; Wang R; MacLennan DH; Dirksen RT; Chen SRW
Biochem J; 2017 Aug; 474(16):2749-2761. PubMed ID: 28687594
[TBL] [Abstract][Full Text] [Related]
18. Role of the proposed pore-forming segment of the Ca2+ release channel (ryanodine receptor) in ryanodine interaction.
Chen SR; Li P; Zhao M; Li X; Zhang L
Biophys J; 2002 May; 82(5):2436-47. PubMed ID: 11964232
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of mutants in the predicted pore region of the rabbit cardiac muscle Ca(2+) release channel (ryanodine receptor isoform 2).
Du GG; Guo X; Khanna VK; MacLennan DH
J Biol Chem; 2001 Aug; 276(34):31760-71. PubMed ID: 11427530
[TBL] [Abstract][Full Text] [Related]
20. RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes.
Robinson RL; Brooks C; Brown SL; Ellis FR; Halsall PJ; Quinnell RJ; Shaw MA; Hopkins PM
Hum Mutat; 2002 Aug; 20(2):88-97. PubMed ID: 12124989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
